Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
7,497 results
  • Clinical update on central hypersomnias. [Review]
  • JTJ Thorac Dis 2018; 10(Suppl 1):S112-S123
  • Pérez-Carbonell L, Leschziner G
  • The central hypersomnias encompass a range of conditions causing persisting or intermittent excessive daytime sleepiness (EDS). These conditions therefore present not infrequently in general clinical...
  • Association between serum hepcidin level and restless legs syndrome. [Journal Article]
  • MDMov Disord 2018 Feb 08
  • Dauvilliers Y, Chenini S, … Lehmann S
  • CONCLUSIONS: In drug-free patients with primary restless legs syndrome, hepcidin level is higher than in controls and may be associated with restless legs syndrome clinical severity. This result emphasizes the complex peripheral iron metabolism deregulation in restless legs syndrome, opening potential perspectives for a personalized approach with a hepcidin antagonist. © 2018 International Parkinson and Movement Disorder Society.
  • Neurodegenerative Disorders and Sleep. [Review]
  • SMSleep Med Clin 2018; 13(1):63-70
  • Malhotra RK
  • Sleep disorders are commonly found in cerebral degenerative disorders. The sleep disorders may be caused by the primary symptoms of the neurologic disease or may result from damage to sleep-controlli...
New Search Next